Literature DB >> 29025158

Cluster randomized trials with a small number of clusters: which analyses should be used?

Clémence Leyrat1,2, Katy E Morgan1, Baptiste Leurent1, Brennan C Kahan3.   

Abstract

Background: Cluster randomized trials (CRTs) are increasingly used to assess the effectiveness of health interventions. Three main analysis approaches are: cluster-level analyses, mixed-models and generalized estimating equations (GEEs). Mixed models and GEEs can lead to inflated type I error rates with a small number of clusters, and numerous small-sample corrections have been proposed to circumvent this problem. However, the impact of these methods on power is still unclear.
Methods: We performed a simulation study to assess the performance of 12 analysis approaches for CRTs with a continuous outcome and 40 or fewer clusters. These included weighted and unweighted cluster-level analyses, mixed-effects models with different degree-of-freedom corrections, and GEEs with and without a small-sample correction. We assessed these approaches across different values of the intraclass correlation coefficient (ICC), numbers of clusters and variability in cluster sizes.
Results: Unweighted and variance-weighted cluster-level analysis, mixed models with degree-of-freedom corrections, and GEE with a small-sample correction all maintained the type I error rate at or below 5% across most scenarios, whereas uncorrected approaches lead to inflated type I error rates. However, these analyses had low power (below 50% in some scenarios) when fewer than 20 clusters were randomized, with none reaching the expected 80% power. Conclusions: Small-sample corrections or variance-weighted cluster-level analyses are recommended for the analysis of continuous outcomes in CRTs with a small number of clusters. The use of these corrections should be incorporated into the sample size calculation to prevent studies from being underpowered.
© The Author 2017; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association

Entities:  

Mesh:

Year:  2018        PMID: 29025158     DOI: 10.1093/ije/dyx169

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  47 in total

1.  An investigation of the effect of smartphone-based pain management application on pain intensity and the quality-of-life dimensions in adolescents with chronic pain: a cluster randomized parallel-controlled trial.

Authors:  Maryam Shaygan; Zahra Jahandide; Nahid Zarifsanaiey
Journal:  Qual Life Res       Date:  2021-05-31       Impact factor: 4.147

2.  Sample size estimation for stratified individual and cluster randomized trials with binary outcomes.

Authors:  Lee Kennedy-Shaffer; Michael D Hughes
Journal:  Stat Med       Date:  2020-01-31       Impact factor: 2.373

3.  Early-Life Nutrition Interventions and Associated Long-Term Cardiometabolic Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Siran He; Aryeh D Stein
Journal:  Adv Nutr       Date:  2021-03-31       Impact factor: 8.701

4.  A simulation study of statistical approaches to data analysis in the stepped wedge design.

Authors:  Yuqi Ren; James P Hughes; Patrick J Heagerty
Journal:  Stat Biosci       Date:  2019-10-23

5.  Association of antenatal vitamin B complex supplementation with neonatal vitamin B12 status: evidence from a cluster randomized controlled trial.

Authors:  Shanshan Li; Baibing Mi; Pengfei Qu; Danmeng Liu; Fangliang Lei; Duolao Wang; Lingxia Zeng; Yijun Kang; Yuan Shen; Leilei Pei; Zhonghai Zhu; Hong Yan; Xin Liu; Shaonong Dang
Journal:  Eur J Nutr       Date:  2020-06-23       Impact factor: 5.614

6.  Randomization-based inference for a marginal treatment effect in stepped wedge cluster randomized trials.

Authors:  Dustin J Rabideau; Rui Wang
Journal:  Stat Med       Date:  2021-05-21       Impact factor: 2.497

7.  Randomization-based confidence intervals for cluster randomized trials.

Authors:  Dustin J Rabideau; Rui Wang
Journal:  Biostatistics       Date:  2021-10-13       Impact factor: 5.899

8.  Design and analysis of a 2-year parallel follow-up of repeated ivermectin mass drug administrations for control of malaria: Small sample considerations for cluster-randomized trials with count data.

Authors:  Conner L Jackson; Kathryn Colborn; Dexiang Gao; Sangeeta Rao; Hannah C Slater; Sunil Parikh; Brian D Foy; John Kittelson
Journal:  Clin Trials       Date:  2021-07-03       Impact factor: 2.486

9.  The impact of improved water supply on cholera and diarrhoeal diseases in Uvira, Democratic Republic of the Congo: a protocol for a pragmatic stepped-wedge cluster randomised trial and economic evaluation.

Authors:  Karin Gallandat; Aurélie Jeandron; Ian Ross; Jaime Mufitini Saidi; Baron Bashige Rumedeka; Vercus Lumami Kapepula; Simon Cousens; Elizabeth Allen; Amy MacDougall; Oliver Cumming
Journal:  Trials       Date:  2021-06-21       Impact factor: 2.728

10.  Ivermectin treatment in humans for reducing malaria transmission.

Authors:  Dziedzom K de Souza; Rebecca Thomas; John Bradley; Clemence Leyrat; Daniel A Boakye; Joseph Okebe
Journal:  Cochrane Database Syst Rev       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.